Home » Newsletters » BioWorld

BioWorld

Feb. 23, 2015

View Archived Issues

Financial scorecard: biotech continues its great start

As February moves into its final trading week the biotech sector continues to roll along, setting the pace for another strong year. Read More

Week in review

Week in Washington

Word on the street

Top 10 deals between biotech companies in 2015

Biotechnology company deals with other biotechnology companies: January 1 - February 19, 2015

Manufacturing, marketing and distribution agreements between biotech companies: January 1 - February 19, 2015

Biotech-biotech collaborations: modified agreements: January 1 - February 19, 2015

Money raised by biotech in 2015 vs. 2014

Money raised by biotech Jan. 1 - Feb. 19, 2015

The week's biggest gainers and losers

BioWorld stock report for public biotechnology companies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...